283 related articles for article (PubMed ID: 20583249)
21. Segmental tuberous sclerosis presenting as unilateral facial angiofibromas.
Trauner MA; Ruben BS; Lynch PJ
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S164-6. PubMed ID: 12894111
[TBL] [Abstract][Full Text] [Related]
22. Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients.
Foster RS; Bint LJ; Halbert AR
Australas J Dermatol; 2012 Feb; 53(1):52-6. PubMed ID: 22309333
[TBL] [Abstract][Full Text] [Related]
23. Segmental tuberous sclerosis in a patient presenting as unilateral facial angiofibromas, periungual fibromas and Shagreen patch.
Sener S; Sasmaz S
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):980-2. PubMed ID: 21845812
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.
Koenig MK; Bell CS; Hebert AA; Roberson J; Samuels JA; Slopis JM; Tate P; Northrup H;
JAMA Dermatol; 2018 Jul; 154(7):773-780. PubMed ID: 29800048
[TBL] [Abstract][Full Text] [Related]
25. Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex.
Lee YI; Lee JH; Kim DY; Chung KY; Shin JU
Dermatology; 2018; 234(1-2):13-22. PubMed ID: 29925060
[TBL] [Abstract][Full Text] [Related]
26. The combination of photodynamic therapy and ultrapulse carbon dioxide laser for facial angiofibromas in tuberous sclerosis complex: A case report.
Wang B; Yao Y; Huang X; Zhang L; Peng D; Zhang G
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102725. PubMed ID: 35041984
[TBL] [Abstract][Full Text] [Related]
27. A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.
Wheless JW; Almoazen H
J Child Neurol; 2013 Jul; 28(7):933-6. PubMed ID: 23680945
[TBL] [Abstract][Full Text] [Related]
28. Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma.
Salido R; Garnacho-Saucedo G; Cuevas-Asencio I; Ruano J; Galán-Gutierrez M; Vélez A; Moreno-Giménez JC
J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1315-8. PubMed ID: 21834948
[TBL] [Abstract][Full Text] [Related]
29. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
[TBL] [Abstract][Full Text] [Related]
30. Multiple facial angiofibromas treated with high-frequency equipment.
Gomes AA; Gomes YV; Lima FB; Pessoa SG
An Bras Dermatol; 2011; 86(4 Suppl 1):S186-9. PubMed ID: 22068806
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing.
Chapas AM; Brightman L; Sukal S; Hale E; Daniel D; Bernstein LJ; Geronemus RG
Lasers Surg Med; 2008 Aug; 40(6):381-6. PubMed ID: 18649382
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.
Wataya-Kaneda M; Ohno Y; Fujita Y; Yokozeki H; Niizeki H; Ogai M; Fukai K; Nagai H; Yoshida Y; Hamada I; Hio T; Shimizu K; Murota H
JAMA Dermatol; 2018 Jul; 154(7):781-788. PubMed ID: 29800026
[TBL] [Abstract][Full Text] [Related]
33. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract][Full Text] [Related]
34. [Multiple and unilateral angiofibromas of the face: forme fruste of Bourneville tuberous sclerosis].
García Muret MP; Pujol RM; de Moragas JM
Ann Dermatol Venereol; 1998 May; 125(5):325-7. PubMed ID: 9747280
[TBL] [Abstract][Full Text] [Related]
35. Cryosurgery: an easy and cheap therapy for facial angiofibromas in tuberous sclerosis.
Schepis C; Siragusa M
Eur J Dermatol; 2010; 20(4):506-7. PubMed ID: 20403796
[No Abstract] [Full Text] [Related]
36. Unilateral angiofibromas. An oligosymptomatic and segmentary form of tuberous sclerosis.
Del Pozo J; Martínez W; Calvo R; Almagro M; Fonseca E
Eur J Dermatol; 2002; 12(3):262. PubMed ID: 11989480
[No Abstract] [Full Text] [Related]
37. Numerous fibrous papules of the face unassociated with any genodermatosis.
Elifritz J; Krishnan RS; Donnelly H
Dermatol Online J; 2007 Oct; 13(4):12. PubMed ID: 18319009
[TBL] [Abstract][Full Text] [Related]
38. Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis.
Kacerovska D; Kerl K; Michal M; Filipova H; Vrtel R; Vanecek T; Zelenakova H; Kraus J; Kodet R; Kazakov DV
J Am Acad Dermatol; 2012 Dec; 67(6):1319-26. PubMed ID: 22552000
[TBL] [Abstract][Full Text] [Related]
39. Treatment of the facial angiofibromas of tuberous sclerosis.
Verheyden CN
Plast Reconstr Surg; 1996 Oct; 98(5):777-83. PubMed ID: 8823013
[TBL] [Abstract][Full Text] [Related]
40. [Laser skin resurfacing and fibrin sealing as successful treatment for facial angiofibromas in tuberous sclerosis].
Pantelis A; Bootz F; Kühnel T
HNO; 2007 Dec; 55(13):1009-11. PubMed ID: 17909732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
